Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.

Revenue
+8.06%
EPS
+8.47%
Free cash flow
+69.5%
Total debt
+8.81%

Quarter to July 2026, against a year earlier

171.89 5.28 −2.98%
Market cap
$48.4B
P/E
33.8×
Fwd P/E
34.1×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100

Agilent Technologies, Inc. (A) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
10-Q Jul 31, 2026 P1I2: 16 added · 12 removed · 69 modified
P2I1A: 16 modified
8-K Aug 26, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 25, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Apr 30, 2026 P1I2: 18 added · 10 removed · 68 modified
P2I1A: 2 added · 1 removed · 11 modified
8-K May 20, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K May 4, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K/A Mar 31, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Mar 31, 2026 5.01 Change in control; 9.01 Financial statements and exhibits Change in control
8-K Mar 18, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Mar 5, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Jan 31, 2026
8-K Feb 25, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Oct 31, 2025 1: 22 added · 19 removed · 61 modified
1A: 8 added · 6 removed · 37 modified
7: 29 added · 32 removed · 89 modified
8-K Nov 24, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 23, 2025 5.02 Departure or appointment of directors or officers
10-Q Jul 31, 2025 P1I2: 9 added · 10 removed · 64 modified
P2I1A: 2 added · 8 modified
8-K Aug 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Apr 30, 2025
8-K May 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jan 31, 2025
8-K Feb 26, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Oct 31, 2024
8-K Nov 25, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jul 31, 2024
8-K Aug 21, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 29, 2024 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 27, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 20, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.